Grantham, Mayo, Van Otterloo & Co (GMO)’s Ovintiv OVV Stock Holding History
Bought
Maintained
Sold
Other funds holding OVV
Grantham, Mayo, Van Otterloo & Co (GMO)'s OVV Position: Q2 2026 in Review
Grantham, Mayo, Van Otterloo & Co (GMO) increased its Ovintiv (OVV) stake by 61% in Q2 2026, buying an estimated $3.43M and bringing the position to 158,997 shares worth $8.37M. The position accounts for 0.02% of the portfolio, ranked #274.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in OVV in Q2 2013 and has held it in 18 quarters since. The position peaked at $39M in Q3 2023. 593 funds tracked by Wall St. Rank hold OVV as of Q2 2026.
- Grantham, Mayo, Van Otterloo & Co (GMO) held 158,997 shares of Ovintiv worth $8.37M as of Q2 2026.
- Grantham, Mayo, Van Otterloo & Co (GMO) bought 60,097 Ovintiv shares in Q2 2026, an estimated $3.43M.
- Ovintiv made up 0.02% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q2 2026, its #274 holding.
- Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Ovintiv in Q2 2013 and has held it in 18 quarters since.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s Ovintiv position peaked at $39M in Q3 2023.
- 593 funds tracked by Wall St. Rank held Ovintiv as of Q2 2026.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.